CHILL THERAPY CIC

Company limited by guarantee

Company Registration Number:
12987779 (England and Wales)

Unaudited statutory accounts for the year ended 30 November 2024

Period of accounts

Start date: 1 December 2023

End date: 30 November 2024

CHILL THERAPY CIC

Contents of the Financial Statements

for the Period Ended 30 November 2024

Profit and loss
Balance sheet
Additional notes
Balance sheet notes
Community Interest Report

CHILL THERAPY CIC

Profit And Loss Account

for the Period Ended 30 November 2024

2024 2023


£

£
Turnover: 41,509 35,597
Cost of sales: ( 21,188 ) ( 29,487 )
Gross profit(or loss): 20,321 6,110
Administrative expenses: ( 35,142 )
Operating profit(or loss): (14,821) 6,110
Profit(or loss) before tax: (14,821) 6,110
Tax: 1,161 ( 1,161 )
Profit(or loss) for the financial year: (13,660) 4,949

CHILL THERAPY CIC

Balance sheet

As at 30 November 2024

Notes 2024 2023


£

£
Current assets
Debtors: 3 6,436 10,907
Cash at bank and in hand: 947 21,006
Total current assets: 7,383 31,913
Creditors: amounts falling due within one year: 4 ( 85 ) ( 1,161 )
Net current assets (liabilities): 7,298 30,752
Total assets less current liabilities: 7,298 30,752
Creditors: amounts falling due after more than one year: 5 ( 9,794 )
Total net assets (liabilities): 7,298 20,958
Members' funds
Profit and loss account: 7,298 20,958
Total members' funds: 7,298 20,958

The notes form part of these financial statements

CHILL THERAPY CIC

Balance sheet statements

For the year ending 30 November 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 6 October 2025
and signed on behalf of the board by:

Name: Michael Morris
Status: Director

The notes form part of these financial statements

CHILL THERAPY CIC

Notes to the Financial Statements

for the Period Ended 30 November 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

CHILL THERAPY CIC

Notes to the Financial Statements

for the Period Ended 30 November 2024

  • 2. Employees

    2024 2023
    Average number of employees during the period 1 1

CHILL THERAPY CIC

Notes to the Financial Statements

for the Period Ended 30 November 2024

3. Debtors

2024 2023
£ £
Trade debtors 6,436 10,907
Total 6,436 10,907

CHILL THERAPY CIC

Notes to the Financial Statements

for the Period Ended 30 November 2024

4. Creditors: amounts falling due within one year note

2024 2023
£ £
Trade creditors 1,161
Other creditors 85
Total 85 1,161

CHILL THERAPY CIC

Notes to the Financial Statements

for the Period Ended 30 November 2024

5. Creditors: amounts falling due after more than one year note

  2023
  £
Other creditors 9,794
Total   9,794

COMMUNITY INTEREST ANNUAL REPORT

CHILL THERAPY CIC

Company Number: 12987779 (England and Wales)

Year Ending: 30 November 2024

Company activities and impact

Chill Therapy CIC is a not for profit organisation, dedicated to provide open water swim courses for people experiencing anxiety and depression and other related illnesses. By providing these courses, we are bringing communities together, combatting loneliness and also making the sea more accessible for all, especially minorities and locals who are on low income and in areas of high deprivation. Chill Therapy CIC is also dedicated in setting up Chill Hubs nationally. We are engaged in educating the community in the benefits of cold water therapy and are dedicated in communicating with, and having referrals from local GPs and Social Prescribers.

Consultation with stakeholders

No consultation with stakeholders

Directors' remuneration

The total amount paid or receivable by directors in respect of qualifying services was £17,150. There were no other transactions or arrangements in connection with the remuneration of directors, or compensation for director’s loss of office, which require to be disclosed.

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
6 October 2025

And signed on behalf of the board by:
Name: Michael Morris
Status: Director